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A COMPARISON BETWEEN ISCHEMIC COMPRESSION AND FOAM ROLLING
IN THE TREATMENT OF ACTIVE RHOMBOID TRIGGER POINTS
Purpose: The purpose of this study was to determine the effectiveness of ischemic
compression therapy versus foam rolling in the treatment of pain associated with active
rhomboid trigger points.
Method: A sample of 30 participants between the ages of 18 and 60 years, took part in this
study. Participants were randomly allocated into two groups of 15 participants each. Group 1
received ischemic compression therapy delivered to the involved rhomboid trigger point and
Group 2 received foam rolling over the involved rhomboid trigger point. The trial period
included six treatments delivered over a period of three weeks with a seventh visit for
measurement only (thus no treatment administered). Subjective and objective data were
collected at visit 1, visit 4, and visit 7. Subjective measurements consisted of the Short-Form
McGill Pain Questionnaire that encompassed the Visual Analogue Scale. Objective
measurements were recorded using a pressure algometer.
Results: According to descriptive and clinical analysis of the subjective and objective data,
Group 2 proved to be slightly more effective than Group 1 with a greater decrease in pain
pressure threshold. Statistically, intragroup and intergroup analysis showed that neither
Group 1 (ischemic compression) nor Group 2 (foam rolling) proved to be superior to the
other.
Conclusion: This study showed that both treatment protocols were effective, however no
treatment proved to be superior. It can be concluded that active rhomboid trigger point pain
can effectively be treated by both ischemic compression and foam rolling, providing the
chiropractic profession with two different post manipulative, home, or alternative treatment
protocols to spinal manipulation.
Key Words: Rhomboid, Trigger Point, Myofascial Pain, Ischemic Compression, Foam
Rolling, Chiropractic.
INTRODUCTION
Myofascial pain is a very common reason for visits to clinical practice and can significantly
affect one’s mood, health related quality of life and function (Gerber, Sikdar, Armstrong,
Diao, Kopekey, Turo, Otto, and Shah, 2013).. Myofascial pain syndrome presents as both
acute and chronic muscular pain characterised by the presence of myofascial trigger points.
A myofascial trigger point (MFTP) is defined as a hyperirritable spot within a taut band of
skeletal muscle that can be either active or latent (Travell and Simons, 1999).
Rhomboid muscles are a typical site for the development of active MFTPs and a frequent
source of interscapular pain that can often be associated with other neck and shoulder
problems (Sultan and El-Tantawi, 2013).
A wide variety of acceptable modalities is available for the treatment of MFTPs including
electrotherapy, dry-needling, and manual therapy. Among manual therapies, pressure
release techniques are very popular in the treatment of MFTP pain. Pressure release
therapy involves the compression of a MFTP for a sustained period of time (Al-Shawabka,
Shenouda and Balbaa, 2013). Ischemic compression and foam rolling are both such
techniques but very few studies have been done to establish which one of the techniques
are more effective in the treatment of MFTP pain.
Myofascial trigger points
MFTPs are classified as either active or latent. Active trigger points are symptomatic as they
elicit pain spontaneously at rest. Latent trigger points only elicit pain when it is manually or
actively stimulated and are therefore considered asymptomatic (Shah and Gilliams, 2008).
The recommended minimum criteria acceptable for the diagnosis of active MFTPs involve
the combined presence of (Fernandes-De-las-Peňas, Campo, Fernandez-Carnero and
Miongolorra-Page, 2005):
- a palpable taut band,
- an exquisite tender spot in the taut band,
- the patient’s recognition of pain as ‘familiar’, and
- pain on stretching the tissue.
There is no accepted reference standard for the diagnosis of MFTPs however, a physical
examination that involves digital palpation is considered reliable and a potentially useful
diagnostic tool (Bron, Franssen, Wensing and Oostendorp, 2007). The reproduction of a
person’s symptoms during palpation increases the certainty of the diagnosis of MFTPs.
The Intergrated Trigger Point Hypothesis provides a possible sequence of MFTP
development (Dommerholt, Bron & Franssen, 2006). The sequence starts with muscle
damage that occurs at a cytoskeletal level and the release of excessive acetylcholine and
incorrect calcium uptake. The increased calcium ions result in sustained sarcomere
contractions, a local energy crisis and compressed capillary circulation. Local hypoxia and a
decrease in pH releases multiple sensitizing substances that initiate and maintain muscle
pain and mechanical hyperalgesia (Shah & Gilliams, 2008)
Rhomboid Muscles
Rhomboid major and minor are separate muscles, however they have the same innervation
and function and are thus commonly referred to as a single muscle or muscle group. The
rhomboid muscles function to control scapular elevation, protraction and rotation to position
the scapulae in order to move the upper limb (Lucas, Rich and Polus, 2010). The rhomboid
muscles typically develop MFTPs in the mid muscle belly and along its attachment site near
the medial border of the scapulae (Travell and Simons, 1999).
The augmented susceptibility of the rhomboid muscles to develop MFTPs can be owed to
three common biomechanical faults; muscular overload during repetitive overhead activities
such as painting or throwing (Bron and Dommerholt, 2012), activity related stresses such as
cradling a phone between the shoulder and the neck (Gerwin and Whyte Furgeson, 2005) as
well as prolonged sitting postures. Computer work requires continuous forward leaning that
result in flexion of the neck and flexion of the thoracic spine that produces sustained
scapular protraction and upward rotation, overstretching the rhomboid muscles, resulting in
pain (Yoo 2013).
Management of Myofascial Pain
The management of symptoms associated with myofascial pain include a wide variety of
acceptable treatment measures that requires the inactivation of MFTPs, the restoration of
the normal muscle length, and elimination or correction of the factors that created or
perpetuated the MFTPs in the first place (Saxena and Chansoria, 2015).
Pressure release therapy is one such modality and is defined by the application of sustained
pressure over a MFTP for a short period of time (Al-Shawabka et al., 2013). Two of the most
popular techniques are ischemic compression and foam rolling. Both these techniques thrive
in applying pressure to a MFTP although the method, application and specificity related to
the trigger point differ completely (Beardsley and Vigotsky, 2015; Travell and Simons, 1999).
Ischemic compression
Ischemic compression is the application of sustained digital pressure directly onto a specific
MFTP, one of the earliest and most commonly used techniques for the treatment of
myofascial pain syndrome (Travell and Simons, 1999).
Pressure allows for local mild trauma within the trigger point which stimulates the release of
vasoactive substances and increases the local metabolism (Turchaninov & Prilutsky, 2009).
Pressure induced ischeamia of trigger points stimulate the nervous system to produce reflex
vasodilation of the constricted capillaries and as a result restore the blood perfusion of the
muscle (Korthuis, 2011).
Moderately strong evidence supports ischemic compression as the technique most
commonly used among chiropractors for immediate pain relief related to MFTPs (Vernon
and Schneider, 2009). In addition, several authors found that ischemic compression is
effective in relieving pain and disability caused by MFTPs in different pathologies such as
cervical spine (Caigne, Dewitte, Coppieters, Van Oosterwijk, Cools and Danneels, 2013) and
shoulder pain (Hains, Descarreaux, and Hains, 2010).
Some studies suggest that an integrative approach might be more beneficial. Nagrale,
Glynn, Joshi and Ramteke (2010) compared the effects of combined muscle energy
techniques, ischemic compression and strain-counterstrain techniques on subjects with
trapezius MFTP pain. Results revealed a greater pain improvement and indicate the
potential benefit of an integrated approach in the treatment of MFTPs.
Foam Rolling
Foam rolling is a new and versatile form of self myofascial release therapy and is very
popular among training institutes and athletes. The term ‘self myofascial release’ could be
confusing to some but it simply refers to myofascial release techniques performed by the
individual themselves (rather than the clinician) that involve the use of a tool, such as a foam
roller, roller massager, or lacrosse ball (Beardsley and Vigotsky, 2015).
Foam rolling utilises a cylindrical tube consisting of high density compressed foam
(Robertson, 2008). The technique of foam rolling is quite simple and self-explanatory and
requires one to start by placing the foam roller between the muscle group being treated and
a hardened surface such as a floor or wall. Following the placement of the foam roller one
uses their bodyweight to apply and off set pressure by slow-rolling movements at an even
pace in each direction.
A research study based on athletic performance concluded that foam rolling significantly
reduces muscle fatigue in athletes, although it has no influence on their performance (Healy,
Hatfield, Blandpied, Dorfman & Riebe, 2014). Foam rolling also proven to reduces arterial
stiffness, improves vascular endothelial function (Takanobu, Mitsuhiko & Komei, 2014),
prevent the formation of adhesions and scar tissue (Hedly, 2010) and increase soft tissue
extensibility (Beardsley & Skarabot, 2015).
MATERIALS AND METHOD
To be included into this study, participants had to:
• Be 18 - 60 years of age.
• Have active rhomboid trigger points according to the following diagnostic criteria
(Travell and Simons, 1999):
- pain at rest or in response to movement,
- the presence of a hyper irritable nodule
- focal tenderness over a palpable nodule,
- characteristic referred pain on palpation
Participants were excluded from this study when they:
• have inter-scapular pain not as a result of active rhomboid trigger points.
• Showed any contraindication to foam rolling and ischemic compression (Starkey,
2013):
- hematoma, acute Inflammation, open wounds, certain skin conditions,
infection, peripheral vascular conditions, osteoporosis, malignancy.
• Used muscle relaxants, NSAIDS or analgesic drugs for the duration of the study
(Fleckenstein, Zaps, Rϋger, Lehmeyer, Freiburg, Lang, Irnich, 2010).
Methodology
Participants were recruited by advertisements (appendix A) placed in and around the
University of Johannesburg’s Doornfontein Campus and the Chiropractic Day Clinic and
some were recruited through word of mouth. The first 30 participants that met the inclusion
criteria and did not meet the exclusion criteria were asked to read an information form
(appendix B) and sign a consent form (appendix C) to ensure the participants’ full
understanding of the procedures involved in this study.
The sample group of 30 participants were randomly divided into one of two groups
consisting of 15 participants each. Participants in Group 1 received ischemic compression
and Participants in Group 2 were instructed and observed foam rolling.
The initial visit consisted of completion of a case history, full physical exam, rhomboid trigger
point examination and the completion of the Short-Form McGill Pain Questionnaire
(appendix G) by the participant. Testing was done with the pressure algometer and
consisted of a single reading over the most active rhomboid trigger point. Participants in
Group 1 received digital ischemic compression directly applied to the active MFTP in the
rhomboid muscle for 60-90 seconds. Participants in Group 2 were instructed and observed
using a high density foam-roller to roll and apply pressure over the entirety of rhomboid
muscle containing the most active trigger point for 2 minutes while being observed by the
researcher.
Participants attended a total of seven visits over a three week period which consisted six
treatments and a seventh (final) visit where only measurements were taken. Each participant
from Group 1 and 2 received six treatments with a minimum of 48 hours between visits to
preserve tissue recovery (Travell and Simons, 1999). On the first, fourth and final visit
participants were required to complete the Short-Form McGill Pain Questionnaire (appendix
G) and undergo testing with the pressure algometer (appendix H).
Subjective measurements
The purpose of the short Form McGill Pain Questionnaire (SF-MPQ) is to obtain different
qualities of the subject’s pain experience. The SF-MPQ (appendix G) is a shorter, less time
consuming version of the original McGill Pain Questionnaire. The SF-MPQ was proven valid
and reliable when results correlated very highly with that of the original McGill pain
questionnaire (Hawker, Milan, Kendzerska and French, 2011).
The SF-MPQ (appendix G) was used to test and retest any subjective changes including
pain improvement or aggravation for the duration of this study. The questionnaire is centred
on its main component called the pain rating index (PRI) that consists of 15 descriptive
words. The descriptive words can further be divided into a sensory subscale (11 words) and
an affective subscale (4 words). These words are rated on an intensity scale of 0 - no pain, 1
– mild pain, 2 – moderate pain and 3 – severe pain. In addition to the PRI, the SF-MPQ also
contains a 100 mm visual analogue scale (VAS) for average pain severity (Dworkin, Turk,
Trudeau, Benson, Biondi, Katz, Kim, 2015). With regards to the scoring and interpretation of
results, there are no critical cut points. A higher score indicates worse pain (Hawker et al.,
2011).
Objective measurement
The pressure algometer is a device used to obtain pain pressure thresholds. Algometer
testing is based on the minimum amount of pressure that induces pain (threshold) and is a
good indication of one’s pain sensitivity. This hand held device consists of a spring operator
force gauge attached to a rounded 1cm rubber tip. The device is calibrated in kg/cm² and
allows for the recording of measurements and resetting the device in between uses
(Harrison and Siskin, 2013).
The pressure algometer was proven reliable when the application force was compared and
highly correlated with that of a force plate (Kinser, Sands, Stone, 2009).
RESULTS
All the subjective and objective data captured during the clinical trial were analysed and
tabulated in order to define any clinically or statistically significant improvements that
occurred in each of the individual treatment groups as well as to determine any significant
difference between the two treatment groups when compared. Normality was established
using the Shapiro-Wilk test, which is used for sample sizes of ≤ 50 participants. The
statistics were found to be not normally distributed, owing to the small sample size and
independent sample groups and therefore non-parametric testing was applied for inter- and
intragroup analysis.
Demographic Analysis
The sample group comprised 17 female and 13 male participants with a mean age of 26.6
years. The minimum age was 22 and the maximum was 58 years. The results of the
Shapiro-Wilk age testing showed a p-value of 0.00 ( 0.05) that indicate that groups are
comparable (Table 4.1).
Clinical Analysis
a) Short-Form McGill Pain Questionnaire
Clinical analysis of the SF-MPQ is illustrated in Figure 4.1 and Figure 4.2. These figures
show the mean pain intensity value of each individual pain descriptor measured in Group 1
and Group 2 at the first, fourth, and seventh visits.
These figures mentioned above indicate an overall mean decrease in pain intensity for
Group 1 and Group 2 respectively between visit 1 and visit 7. Both these figures indicated
no mean values for fearful, punishing cruel, and splitting as no participant in Group 1 or
Group 2 presented with these types of pain.
b) Visual Analogues Scale
Figure 4.3 illustrates the mean VAS readings measured at the first, fourth, and seventh visits
and indicates an overall decrease in self-reported pain. The mean percentage decrease in
self-reported pain severity measured by the VAS for Group 1 was 68.0%, for Group 2 was
76.6%, and for the Total Sample Group was 72.4%.
c) Pressure Algometer
Figure 4.4 illustrates the mean pressure algometer readings in kg/cm² measured at the first,
fourth, and seventh visits. This indicates that the mean percentage increase in pain pressure
threshold measured by the pressure algometer for Group 1 was 43.9%, for Group 2 was
48.8%, and for the Total Sample Group 45.2%.
Intragroup Analysis
a) Short-Form McGill Pain Questionnaire
Table 4.2 displaying the results of the Friedman’s Test refers to five pain descriptions that
had a statistically significant (p  0.05) decrease in pain intensity in either Group 1 or Group
2 or in both groups: aching, cramping, gnawing, stabbing, and throbbing. All other pain
descriptors proved to be statistically insignificant, as all p-values were p > 0.05 or had no p-
value (NV). Analysis of Group 1 indicates that a statistically significant (p  0.05) decrease
in pain intensity found for cramping pain with 28.3% improvement, stabbing pain with 21.5%
improvement, and throbbing pain with a 28.3% improvement. Changes in aching pain and
gnawing pain were statistically insignificant (p > 0.05). Analysis of Group 2 indicates that a
statistically significant (p  0.05) decrease in pain intensity was found for aching pain with
36.8% improvement, cramping pain with a 28.3% improvement, and gnawing pain with a
24.8% improvement. Changes in stabbing pain and throbbing pain were statistically
insignificant (p > 0.05).
Table 4.3 and Table 4.4 refers to the non-parametric Wilcoxon Signed Rank Test used to
determine between which visits the statistically significant reduction in pain intensity
(according to the SF-MPQ) occurred in Group 1 and Group 2 respectively. Group 1 analysis
shows that the cramping, stabbing and throbbing pain description indicate a statistically
significant difference (p  0.05) between visits 1 and 4  and between visits 1 and 7 but not
between visits 4 and 7 (p> 0.05). Group 2 analysis shows that the aching and cramping pain
description indicate a statistically significant difference (p  0.05) between visits 1 and 4 and
between visits 1 and 7, but not between visits 4 and 7 (p>0.05). Analysis of the gnawing pain
description indicates that a statistically significant difference ( 0.05) was found between
visits 4 and 7 and visits 1 and 7 but not between visits 1 and 4 (p.0.05) This indicates that
the reduction in cramping, stabbing throbbing and aching pain occurred in earlier visits,
however gnawing pain only in later visits.
b) Visual Analogue Scale
According to the Friedman’s Test results displayed in Table 4.5, Group 1 had a mean rank
VAS value of 2.83 at the first visit, 2.03 at fourth visit, and 1.13 at the seventh visit. A
decrease in self-reported pain of 60.1% was noted between the first and seventh visits. The
p-value of 0.00 ( 0.05) indicates that the reduction in pain was statistically significant. Group
2 had a mean rank VAS value of 2.87 at the first visit, 2.00 at fourth visit, and 1.13 at the
seventh visit. A decrease in self-reported pain of 60.6% was noted between the first and
seventh visits. The p-value of 0.00 ( 0.05) indicates that the reduction in pain was
statistically significant.
Analysis of Group 1 and Group 2 by the Wilcoxon Signed Rank Tests indicates that a
statistically significant difference ( 0.05) was found between visits 1 and 4, visits 1 and 7
and visits 4 and 7. This indicates a gradual improvement in VAS readings throughout the
course of the trial period for both groups (Table 4.6).
c) Pressure Algometer
Friedman’s test was used for intragroup analysis and displayed in Table 4.7. Group 1 had a
mean rank pressure algometer value of 1.13 at the first visit, 2.00 at the fourth visit, and 2.87
at the seventh visit. A mean percentage improvement in pain pressure threshold of 60.6%
was noted between the first and seventh visits. The p-value of 0.00 ( 0.05) indicates that
the improvement was statistically significant. Group 2 had a mean rank pressure algometer
value of 1.33 at the first visit, 1.78 at fourth visit, and 2.93 at the seventh visit. A mean
percentage improvement in pain pressure threshold of 54.6% was noted between the first
and seventh visits. The p-value of 0.00 ( 0.05) indicate that the improvement was
statistically significant.
According to the Wilcoxon Rank Test displayed in Table 4.8, Group 1 shows a statistically
significant difference (p 0.05) between visits 1 and 4, visits 1 and 7, and visits 4 and 7. This
indicates a gradual improvement throughout the course of the trial period. Group 2 shows a
statistically significant difference (p 0.05) between visits 1 and 7 and between visits 4 and
7, but not between visits 1 and 4 (p>0.05). This indicates that the improvement occurred in
later visits.
Intergroup Analysis
a) Short-Form McGill Pain Questionnaire
The non-parametric Mann-Whitney U Test was used to compare the mean rank pain
intensity values of the two groups, for each individual pain descriptor. Table 4.9 indicates
that no statistically significant difference was found between the two groups at any given visit
for a specific description of pain. All p-values presented in the above table proved to be
insignificant (p > 0.05).
b) Visual Analogues Scale
Table 4.10 refers to the non-parametric Mann-Whitney U Test used to compare the mean
rank VAS values of the two groups. The baseline reading of the p-value at visit 1 (p=0.63)
started at greater than 0.05, and therefore groups started off comparable. The p-value
remained greater at visit 4 (p=0.42) and at visit 7 (p=0.22), indicating no statistically
significant change in the mean VAS readings between Group 1 and Group 2.
c) Pressure Algometer
Table 4.11 refers to the non-parametric Mann-Whitney U Test used to compare the mean
rank pressure algometer values of the two groups. The baseline reading of the p-value at
visit 1 (p=0.58) started at greater than 0.05, and therefore groups started off comparable.
The p-value remained greater at visit 4 (p=0.71) and at visit 7 (p=0.34), indicating no




The demographic data discuss the characteristics of the sample population that participated
in this clinical trial wth regards to age and gender analysis.
Table 4.1 conclude that the sample group comprised 17 female and 13 male participants
with a mean age of 26.6 years. The minimum age was 22 and the maximum was 58 years.
Owing to the high levels of activity in younger adults, the prevalence of interscapular pain in
this population is higher than in other populations (Hutson and Speed, 2011).
b) Short-Form McGill Pain Questionnaire
The descriptive and clinical statistics of the SF-MPQ describe and summarize data with
regards to pain descriptions used by participants to define their rhomboid MFTP pain. The
most frequent pain descriptors used by the sample group in this study were aching,
cramping, exhausting, gnawing, stabbing, tender, throbbing, and sharp (figures 4.1 and 4.2).
Narrative interviews done by Dudgeon, Ehde, Cardenas, Engel, Hoffman and Jensen (2005)
with patients suffering from chronic pain, found that ‘aching’ pain is the most frequently used
pain description on the SF-MPQ in patients with nociceptive pain. As stated earlier by
Dworkin et al. (2015), the SF-MPQ consists of 15 descriptive words that can be divided into
sensory and affective subscales. All of the frequently used descriptors were from the
sensory subscale and is a common finding among nociceptive pain trials (Lin, Kupper,
Gammaitoni, Galer and Jensen, 2011). This could possibly explain why some descriptive
words from the SF-MPQ were more frequently used than others in this clinical trial.
Regarding the results of the Friedman test (table 4.2), the ischemic compression group had
a greater improvement in pain experience concerning three types of pain (cramping,
stabbing, and throbbing) whereas the foam rolling group had a greater improvement in only
two types of pain (aching and gnawing). When being asked to pick a pain descriptor from a
questionnaire, participants will generally endorse those descriptions presented to them on a
list, but not necessarily volunteer them without a cue (Lin et al., 2011). This can serve as a
possible reason for the discrepancy in these findings.
With regards to Table 4.3 and Table 4.4, both groups showed an improvement in pain
experience over the three week treatment period (visit 1 to 7). However, the majority pain
descriptors of Group 1 and Group 2 showed improvement between visits 1 and 4. It can be
concluded that both ischemic compression and foam rolling showed a statistically significant
improvement in rhomboid MFTP pain within the first four treatments and could be considered
effective in the short term.
Table 4.9 indicated that there were no statistical significant difference between the two
groups when compared as all the p-values were found to be greater or equal to 0.05 (p >
0.05). This indicates that both ischemic compression and foam rolling proved to be effective
in reducing rhomboid MFTP pain, with no superior protocol.
c) Visual Analogues Scale
A visual or verbal numeric pain rating scale is commonly used in clinical practice where
patients rate their own pain. The advantages of numeric scales are their simplicity,
reproducibility, and sensitivity to small changes in pain
Clinically, the self-reported pain in the ischemic compression group improved by 67.98%,
however a slightly greater improvement of 76.62% was noted in the foam rolling group
(figure 4.3). There are a couple of possible explanations for this finding. Research by Crane,
Ogborn, and Cupido (2012) reported that rolling massage decreases pain and inflammation,
potentially by promoting blood flow to areas of ischemia such as a MFTPs and the muscle-
tendon interface. The foam rolling group recorded substantially less muscle soreness which
is consistent with the clinical findings of this study where the foam rolling group stated less
self-reported pain compared to the ischemic compression post treatment.
Illustrated in table 4.5, both groups showed a statistically significant (p 0.05) reduction in
pain severity, with a p-value of p= 0.00. This indicates that both ischemic compression and
foam rolling reduced pain related to rhomboid MFTPs significantly. In a recent study that was
investigating the effects of ischemic compression on MFTPs of the trapezius muscle, it
stated that ischemic compression by means of slowing down blood flow and forcing tension
out the muscle resulted in desensitisation of the nerve endings in the surrounding skin (Iqbal,
Khan and Miraj, 2010). This could possibly explain why participants for the ischemic
compression group reported a significant reduction in pain.
Table 4.6 concludes that both ischemic compression and foam rolling treatments showed a
consistent reduction in pain severity over seven visits in a three week treatment period.
Table 4.10 indicates a p-value at visit 1 (p=0.63) that started at greater than 0.05 and
remained greater at visit 4 (p=0.42) and at visit 7 (p=0.22), indicating no statistically
significant difference between Group 1 and Group 2 when compared. This indicates that
both ischemic compression and foam rolling is effective in reducing pain, however no
treatment protocol is found to be superior to the other with regards to subjective data
gathered by the VAS.
d) Pressure Algometer
Pain pressure threshold can be defined as the minimum force that induces pain and
evaluates sensitivity or tenderness. The pressure algometer used in this study was
calibrated between 0 and 5 kg/cm² with a high value indicating a higher pain pressure
threshold, in other words reduced pain sensitivity.
Clinically, the sample group in total showed an improvement in pain pressure threshold, as
the mean algometer values in both groups increased between pre and post treatment (figure
4.4). The ischemic compression group improved by 43.95%, however a slightly greater
improvement of 48.87% was noted in the foam rolling group. The most plausible explanation
proposed for this finding could be the non-localized effect of foam rolling. The rhomboid
muscles can exhibit a total of three MFTPs. One could assume that some participants
presented with latent or active rhomboid MFTPs other than the primary active trigger point.
The application of pressure via a foam roller is over a generalised muscle area which
stimulates a wider range of mechanoreceptors and proprioceptors in the skin and muscle
which can lead to a reduction in perceived pain locally and distant form the involved or
primary MFTP.
Illustrated in table 4.7, both groups as well as the sample group in total showed a statistically
significant (p 0.05) increase in pain pressure threshold, with a p-value of p= 0.000. These
results indicate that both ischemic compression and foam rolling over MFTPs increased pain
pressure threshold significantly. These findings came in agreement with reports from other
authors including Fryer and Hodgson (2005), Chaitow (2009), Caigne et al. (2013), Al-
Shawabka et al. (2013) and most recently Abu-Taleb et al. (2016), who found that pressure
release therapy increases pain pressure threshold and subsequently reduces pain sensitivity
over MFTPs.
With reference to table 4.8, ischemic compression exhibited a consistent reduction in pain
pressure threshold over seven visits in a three week treatment period. Foam rolling however
was more effective in improving pain pressure threshold later in the treatment period
(between visits 4 and 7).
Table 4.11 indicates a p-value at visit 1 (p=0.58) that started at greater than 0.05 and
remained greater at visit 4 (p=0.71) and at visit 7 (p=0.34). It indicates no statistically
significant difference between Group 1 and Group 2 for the duration of the treatment period.
This shows that both ischemic compression and foam rolling are effective in improving pain
pressure threshold however no treatment protocol is found to be superior with regards to
objective data gathered by the pressure algometer.
CONCLUSION
According to clinical results, foam rolling showed a slightly greater improvement than
ischemic compression which in its turn promotes further research as foam rolling is still a
fairly new and promising intervention and little evidence currently support this finding.
Statistical results indicate that both treatment protocols are effective in reducing rhomboid
MFTP pain, however the clinical difference is statistically insignificant and in fact owed to
chance. In conclusion, no treatment protocol was superior to the other in the treatment of
rhomboid trigger point pain.
The outcome of this study suggests that patients with rhomboid trigger point pain can be
treated effectively seen that active trigger points respond proficiently to both ischemic
compression and foam rolling. Both groups showed a reduction in self-reported pain and a
decrease in pain pressure threshold over active rhomboid trigger points.
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Figure 4.2 Group 2 – Changes in the Mean Pain Intensity of the SF-MPQ











































































































Figure 4.4 Changes in the Mean Pain Pressure Threshold of the Pressure Algometer
TABLES
Table 4.1: Demographic Data within the sample of 30 participants















Table 4.2 Friedman Test for Change in SF-MPQ Pain Descriptors and Values
(Statistically Significant)
Friedman Test : Statistically Significant values
ACHING
Group 1 Group 2











































0.00Visit 4 2.0 1.87
Visit 7 1.77 1.6
CRAMPING
Group 1 Group 2




0.01Visit 4 1.97 1.93
Visit 7 1.77 1.7
GNAWING
Group 1 Group 2




0.03Visit 4 2.10 2.2
Visit 7 1.87 1.63
STABBING
Group 1 Group 2




0.06Visit 4 1.83 2.0
Visit 7 1.83 1.77
THROBBING
Group 1 Group 2




0.31Visit 4 1.93 2.1
Visit 7 1.70 1.87
Table 4.3 Group 1 - Wilcoxon Signed Rank Test for Changes over Time (SF-MPQ)
Group 1 : Wilcoxon Signed Rank Test
Description p-value
Visit 1-4 Visit 1-7 Visit 4-7
Cramping 0.05 0.01 0.10
Stabbing 0.04 0.04 1.00
Throbbing 0.03 0.02 0.10
Table 4.5 Friedman Test for Changes in VAS mean values
Friedman Test
Group Reading Number Mean p-value
Group 1 1 (Visit 1) 2.83 0.00 thus ≤ 0.05
2 (Visit 4) 2.03
3 (Visit 7) 1.13
Group 2 1 (Visit 1) 2.87 0.00 thus ≤ 0.05
2 (Visit 4) 2.0
3 (Visit 7) 1.13
Total Sample Group 1 (Visit 1) 2.85 0.00 thus ≤ 0.05
2 (Visit 4) 2.02
3 (Visit 7) 1.13
Table 4.6 Wilcoxon Signed Rank Test for Changes over Time (VAS)
Wilcoxon Signed Rank Test
Visits p-value
Group 1 Group 2 Group 3
Visit 1 – Visit 4 0.01 0.00 0.00
Visit 1 – Visit 7 0.00 0.00 0.00
Visit 4 – Visit 7 0.00 0.00 0.00
Table 4.7 Friedman Test for Changes in Pressure Algometer Mean Values
Friedman Test
Group Reading Number Mean Rank p-value
Group 1 1 (Visit 1) 1.13 0.00 thus p ≤ 0.05
2 (Visit 4) 2.00
3 (Visit 7) 2.87
Group 2 1 (Visit 1) 1.33 0.00 thus p ≤ 0.05
2 (Visit 4) 1.73
3 (Visit 7) 2.93
Table 4.8 Wilcoxon Signed Rank Test for Changes over Time
(Pressure Algometer)
Wilcoxon Signed Rank Test
Visits p-value
Group 1 Group 2 Group 3
Visit 1 – Visit 4 0.00 0.21 0.00
Visit 1 – Visit 7 0.00 0.00 0.00
Visit 4 – Visit 7 0.00 0.00 0.00
Table 4.9 Mann-Whitney U test for Comparison of Means (SF-MPQ)
Mann-Whitney U Test
p-value
















Table 4.10 Mann-Whitney U test for Comparison of Means (VAS)
Mann-Whitney U Test
Reading Group 1 Group 2
1 (visit 1) Mean Rank 14.73 16.27
p-value 0.63 thus p > 0.05
2 (visit 4) Mean Rank 14.27 16.73
p-value 0.42 thus p > 0.05
3 (visit 7) Mean Rank 17.47 13.53
p-value 0.22 thus p > 0.05
Table 4.11 Mann-Whitney U test for Comparison of Pressure Algometer Means
Mann-Whitney U Test
Reading Group 1 Group 2
1 (visit 1) Mean Rank 14.60 16.40
p-value 0.58 thus p > 0.05
2 (visit 4) Mean Rank 16.10 14.90
p-value 0.71 thus p > 0.05
3 (visit 7) Mean Rank 14.00 17.00
p-value 0.34 thus p > 0.05
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100 WORD ABSTRACT
Purpose: To compare ischemic compression and foam rolling in the treatment of active
rhomboid trigger points.
Method: Thirty participants were randomly allocated to either the group who received
ischemic compression (Group 1) or the group who received foam rolling (Group 2). Both
groups underwent data capturing on the first, fourth and seventh consultation. This consisted
of completing a Short-Form McGill Pain Questionnaire, Visual Analogues Scale and
Algometer testing.
Results: The intragroups analysis revealed both ischemic compression and foam rolling to
be effective in the treatment of active rhomboid trigger points; however intergroup analysis
shows no statistically superior treatment protocol.
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